Supplementary Tables S5, S6, S7, S8 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

Supplementary Tables S5, S6, S7, S8. mRNA expression data for EGFR ligands as measured by RNAseq from The Cancer Genome Atlas (TCGA) across 14 cancer indications or by RT-qPCR of colorectal cancer FFPE samples. Table S5: Summary of TCGA datasets included in the analysis. Table S6: Raw and normalized expression data from TCGA. Table S7: EGFR ligand expression measured by RT-qPCR on commercially-obtained colorectal cancer FFPE samples. Table S8: Pairwise correlations of EGFR ligands across four TCGA indications.

补充表格S5、S6、S7、S8。包含于癌症基因组图谱（TCGA）中的EGFR配体mRNA表达数据，通过RNA测序技术获得，覆盖14种癌症类型，或通过实时定量PCR（RT-qPCR）对结直肠癌FFPE样本进行测定。表格S5：分析中包含的TCGA数据集概要。表格S6：TCGA的原始及标准化表达数据。表格S7：通过RT-qPCR技术在商业获得的结直肠癌FFPE样本上测定的EGFR配体表达。表格S8：EGFR配体在四个TCGA指示征之间的成对相关性。